2023 ESMO ASIA | 翰森制药阿美替尼5篇创新成果入选国际学术盛会
迷你口头报告:1篇
研究数据:2篇
病例报道:1篇
A Lung Squamous Cell Carcinoma(LUSC)Patient with Complex Gene Mutations and PD-L1 Expression Responded to Aumolertinib
研究设计:1篇
关于翰森制药
迷你口头报告:1篇
研究数据:2篇
病例报道:1篇
A Lung Squamous Cell Carcinoma(LUSC)Patient with Complex Gene Mutations and PD-L1 Expression Responded to Aumolertinib
研究设计:1篇
关于翰森制药